Cargando…
Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel Treatment
INTRODUCTION: Myasthenia gravis (MG) is a devastating acquired autoimmune disease that can seriously affect the patient’s quality of life. It is also a common complication of thymoma. Previous studies have shown that docetaxel alleviates myasthenic symptoms in thymoma with MG (TMG). However, little...
Autores principales: | Yang, Hongxia, Qi, Guoyan, Dong, Huimin, Liu, Ze, Ma, Mei, Liu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043105/ https://www.ncbi.nlm.nih.gov/pubmed/36786935 http://dx.doi.org/10.1007/s40120-023-00442-3 |
Ejemplares similares
-
Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent
por: Qi, Guoyan, et al.
Publicado: (2017) -
Docetaxel/cisplatin Therapy in Myasthenia Gravis with Hypertension/diabetes
por: Qi, Guoyan, et al.
Publicado: (2017) -
Developing and validating a nomogram to predict myasthenia gravis exacerbation in patients with postoperative thymoma recurrence
por: Cheng, Biqi, et al.
Publicado: (2022) -
Multiple Thymoma with Myasthenia Gravis
por: Seo, Dong Hyun, et al.
Publicado: (2017) -
Thymoma-Associated Myasthenia Gravis With Myocarditis
por: Sarwar, Shihab, et al.
Publicado: (2023)